We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBST
351
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$515K 0.05%
7,372
+1,700
+30% +$116K
FAST icon
352
Fastenal
FAST
$54.8B
$513K 0.05%
41,440
+13,600
+49% +$168K
MSCC
353
DELISTED
Microsemi Corp
MSCC
$512K 0.05%
19,140
+7,260
+61% +$181K
GWW icon
354
W.W. Grainger
GWW
$64.2B
$511K 0.05%
2,010
+500
+33% +$128K
STJ
355
DELISTED
St Jude Medical
STJ
$510K 0.05%
7,370
– –
DAR icon
356
Darling Ingredients
DAR
$9.32B
$509K 0.05%
24,362
– –
RAD
357
DELISTED
Rite Aid Corporation
RAD
$505K 0.05%
3,524
-1,973
-36% -$291K
BFH icon
358
Bread Financial
BFH
$4.32B
$503K 0.05%
2,243
+627
+39% +$128K
EL icon
359
Estee Lauder
EL
$30.4B
$503K 0.05%
6,780
+1,800
+36% +$132K
CSII
360
DELISTED
Cardiovascular Systems, Inc.
CSII
$497K 0.05%
15,942
+930
+6% +$26.8K
APH icon
361
Amphenol
APH
$185B
$496K 0.05%
41,200
+11,200
+37% +$133K
MET icon
362
MetLife
MET
$62.4B
$495K 0.05%
9,987
-20,568
-67% -$962K
CMCSA icon
363
Comcast
CMCSA
$87.3B
$493K 0.05%
18,350
-108,420
-86% -$2.79M
JCI icon
364
Johnson Controls International
JCI
$85.1B
$491K 0.05%
9,388
-3,724
-28% -$185K
LXP icon
365
LXP Industrial Trust
LXP
$3.52B
$491K 0.05%
8,922
– –
DOV icon
366
Dover
DOV
$26.7B
$487K 0.05%
6,636
+1,857
+39% +$130K
OKE icon
367
Oneok
OKE
$56.7B
$487K 0.05%
7,160
+2,000
+39% +$127K
SNDK
368
DELISTED
SANDISK CORP
SNDK
$486K 0.05%
4,650
– –
DHC
369
Diversified Healthcare Trust
DHC
$2.15B
$482K 0.05%
20,019
+6,761
+51% +$158K
HRI icon
370
Herc Holdings
HRI
$4.78B
$481K 0.05%
5,717
+3,034
+113% +$256K
TRV icon
371
Travelers Companies
TRV
$81.1B
$478K 0.05%
5,080
-6,563
-56% -$599K
ADI icon
372
Analog Devices
ADI
$172B
$477K 0.05%
8,820
– –
PNC icon
373
PNC Financial Services
PNC
$99.1B
$477K 0.05%
5,360
-9,698
-64% -$828K
TGT icon
374
Target
TGT
$66.3B
$473K 0.05%
8,160
-14,403
-64% -$847K
CEB
375
DELISTED
CEB Inc.
CEB
$472K 0.05%
6,921
– –
13 14
15
16 17

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.